Top 10 AI in Healthcare Solution Providers 2024
In today’s healthcare landscape, the need for Artificial Intelligence (AI) has never been more critical. As healthcare providers face mounting pressures from increasing patient volumes, the demand for precision diagnostics, and the necessity to control rising costs, AI emerges as a transformative force capable of addressing these complex challenges. AI’s potential to analyze vast amounts of data, predict patient outcomes, and streamline operations is revolutionizing the way healthcare is delivered, offering a pathway to more efficient, accurate, and personalized care.
Telemedicine and remote patient monitoring have seen a significant uptick, driven by the need for continuous care and monitoring outside traditional clinical settings. Predictive analytics and AI-driven diagnostics are becoming central to early disease detection and personalized treatment plans. Moreover, AI is increasingly being utilized to enhance operational efficiencies, from optimizing hospital workflows to managing patient records and billing processes. The convergence of AI with other advanced technologies, such as robotics and genomics, is further expanding the horizons of what is possible in healthcare.
In this special edition of Medhealth Outlook magazine, we are proud to present the Top 10 AI in Healthcare Solution Providers of 2024. These innovative companies are at the forefront of integrating AI into healthcare, creating solutions that are reshaping the industry. From enhancing diagnostic accuracy to optimizing treatment plans and improving patient management, these trailblazers are leveraging cutting-edge AI technologies to make a significant difference in patient care and operational efficiency. Their ground-breaking work not only addresses the current needs of the healthcare system but also paves the way for a future where AI-driven insights and innovations lead to superior health outcomes and a more sustainable healthcare ecosystem.
Management:
Azar Azad, MLD, PhD
Designation:
CEO
Headquarters:
Toronto, Canada
Website:
ai-vali.com
A.I. VALI Inc., is a leading company in the artificial intelligence industry. The company specialize in providing cutting-edge AI solutions to address various challenges faced by healthcare systems. As a pioneer in the industry, A.I. VALI offer advanced AI algorithms and tools that can process and analyze large datasets quickly and accurately. These tools help healthcare systems derive valuable insights from their data, leading to better decision-making and strategic planning.
Augmedix
Management:
Emmanuel Krakaris
Designation:
President & CEO
Headquarters:
San Francisco, CA
Website:
augmedix.com
Augmedix uses ambient AI to relieve clinicians of administrative tasks, allowing them to focus on patient care. The platform converts natural conversations into medical notes, structured data, and point-of-care notifications, enhancing efficiency and clinical decision-making. Leveraging data from millions of interactions, Augmedix partners with hospitals and health systems to improve clinical, operational, and financial outcomes.
Management:
Joseph DeVivo
Designation:
President, CEO, & Chairman of the Board
Headquarters:
Burlington, MA
Website:
butterflynetwork.com
Butterfly Network's mission is to provide accessible clinical insights through innovative ultrasound technology enhanced by artificial intelligence. Their high-quality, affordable, and user-friendly ultrasound devices enable better clinical decisions by delivering precise information at the point of care. Butterfly Network ensures "seeing is knowing" in hospitals, communities, and homes, benefiting patients worldwide.
Cleerly
Management:
James K. Min
Designation:
Founder & CEO
Headquarters:
Denver, CO
Website:
cleerlyhealth.com
Cleerly is the company on a mission to eliminate heart attacks by creating a new standard of care for the diagnosis of heart disease. Through its AI-empowered solutions, Cleerly supports comprehensive phenotyping of coronary artery disease, through its evaluation of advanced non-invasive CT imaging. Cleerly’s approach is grounded in nearly 20 years of science from landmark multi-center clinical trials.
CloudMedx
Management:
Tashfeen Suleman
Designation:
CEO
Headquarters:
Palo Alto, CA
Website:
cloudmedxhealth.com
CloudMedx is a global team of engineers, data scientists, doctors, innovators, and creative thinkers dedicated to simplifying and improving healthcare through technology. They integrate all data sources and systems for a comprehensive view and automate processes for efficiency. This approach enhances clinical, operational, and financial outcomes, coordinating results in unprecedented ways.
Corti
Management:
Andreas Cleve
Designation:
Co-Founder & CEO
Headquarters:
København K, Denmark
Website:
corti.ai
Corti offers healthcare practitioners a voice-based AI platform for analyzing patient interviews, helping them to make decisions faster, and more accurately during a medical consultation. Healthcare organizations use Corti to optimize their patient interview processes in order to save time, reduce costs, and improve patient quality of care.
Oncora Medical
Management:
David Lindsay
Designation:
Co-Founder & CEO
Headquarters:
Philadelphia, PA
Website:
oncora.ai
Oncora develops machine learning and workflow software to help doctors, patients, and scientists personalize cancer treatments. Their flagship product, Oncora Patient Care, streamlines documentation for oncology physicians at large and medium-sized cancer centers in the US. By ingesting prior notes, radiology reports, pathology reports, and structured data, the software ensures comprehensive documentation for clinical, billing, and accreditation needs. Research shows it saves physicians over 67% of their time per treatment.
Management:
Mark Hammar
Designation:
CEO
Headquarters:
Toronto, Canada
Website:
proteocyte.com
Proteocyte AI is a Med-tech company developing advanced prognostic lab tests to predict patient risk of developing cancer. Founded in 2011, Proteocyte AI identified the need to provide healthcare professionals with more objective and quantifiable information that would significantly improve the outcome for their patients. Proteocyte AI offers personalized medicine with AI driven technology.
Management:
Eric Lefkofsky
Designation:
Founder & CEO
Headquarters:
Chicago, IL
Website:
tempus.com
Tempus is revolutionizing precision medicine by applying AI in healthcare, extracting insights from a vast library of clinical and molecular data. Their analytical machine learning platform empowers physicians to make real-time, data-driven decisions for personalized care and targeted therapies. Tempus also collaborates with partners to facilitate the discovery, development, and delivery of optimized therapeutic options through unique solution sets.
Viz.ai
Management:
Chris Mansi
Designation:
Co-Founder & CEO
Headquarters:
San Francisco, CA
Website:
viz.ai
Viz.ai is the pioneer in the use of AI algorithms and machine learning to increase the speed of diagnosis and care, covering more than 220 million lives across 1,600+ hospitals and health systems in the U.S. and Europe. The AI-powered Viz.ai® One is an intelligent care coordination solution that identifies more patients with a suspected disease, informs critical decisions at the point of care, and optimizes care pathways and helps improve outcomes.
